Korro Bio, Inc.
KRRO
$12.31
-$0.29-2.30%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/15/2026
-
Ticker Report
3/14/2026
-
Ticker Report
3/14/2026
-
Tickeron - Technical Analysis
3/13/2026
-
Simply Wall St
3/13/2026
-
TipRanks Financial Blog
3/13/2026
-
Market News Video
3/13/2026
-
Benzinga
3/13/2026
-
Ticker Report
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/13/2026
-
TipRanks Financial Blog
3/13/2026
-
TipRanks Financial Blog
3/13/2026
-
Zolmax
3/13/2026
-
Ticker Report
3/13/2026
-
Ticker Report
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/12/2026
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 12, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 468 1999
Address
60 First Street
2nd Floor - Suite 250
Cambridge, MA 02141
2nd Floor - Suite 250
Cambridge, MA 02141
Country
Year Founded
Business Description
Sector
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent...
more